CASP3 and ischemia: Chen et al. found that the ventricular infusion of caspase-3 inhibitors reduced caspase-3 levels in the hippocampal area, dramatically diminished cell mortality in the CA1 region, and mitigated DNA breakdown after 7 days of ischemia [49].